Enanta Pharmaceuticals (ENTA) News Today

Enanta Pharmaceuticals logo
$7.61 -0.37 (-4.64%)
As of 03:58 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Why Is Enanta Pharmaceuticals Dropping Today?

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) may face mixed sentiment: HC Wainwright raised several longer-term earnings forecasts, while JPMorgan lowered its price target. The stock is trading near its 52-week low, leaving it sensitive to analyst changes.

  • Positive Sentiment: HC Wainwright maintained its Buy rating and $20 target, while improving its FY2027–FY2030 EPS forecasts, signaling expectations for smaller losses than previously projected in those years. HC Wainwright estimates
  • Negative Sentiment: JPMorgan cut its price target to $17 from $19. Although it retained an Overweight rating, the reduction may weigh on sentiment and tempers the otherwise optimistic analyst outlook.
Posted 7m agoAI Generated. May Contain Errors.

Enanta Pharmaceuticals Latest News

What is HC Wainwright's Forecast for ENTA Q1 Earnings?
Enanta Pharmaceuticals Fiscal Q4 Loss Narrows, Revenue Falls
Enanta Pharmaceuticals, Inc. Announces Executive Changes
Enanta Pharmaceuticals (ENTA) Gets a Buy from J.P. Morgan
Enanta Pharmaceuticals: Fiscal Q1 Earnings Snapshot
Enanta Pharmaceuticals Insider Ups Holding During Year
Enanta reports Q4 EPS (87c), consensus ($1.01)
Enanta stock tumbles after RSV drug misses primary endpoint

Enanta Pharmaceuticals Media Mentions By Week

Enanta Pharmaceuticals Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ENTA
News Sentiment
▼
0.37

0.40
▲
Average
Healthcare
News Sentiment

Enanta Pharmaceuticals News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ENTA Articles
This Week
▼
17

2
▲
ENTA Articles
Average Week

Enanta Pharmaceuticals Trends on MarketBeat

This week vs. last week
New Followers
2
Page Views
1,054
+37%
Get Enanta Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ENTA and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Enanta Pharmaceuticals dated 11/20/2026.
From Our Partners